w. j. fenton md, frcpc, facp clinical professor of medicine, u of s tb 101 for primary care...
TRANSCRIPT
![Page 1: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/1.jpg)
W. J. Fenton MD, FRCPC, FACPClinical Professor of Medicine, U of S
TB 101 for Primary Care
Providers
![Page 2: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/2.jpg)
Patient First
![Page 3: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/3.jpg)
Patient First
TBC & partners have always put the patient first:• Mobile clinics• Try to be flexible concerning drug delivery• Incentives if need be
In all we do collectively, we constantly should strive to make the patient first in our thinking and our actions.
![Page 4: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/4.jpg)
Think TB
![Page 5: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/5.jpg)
While you are thinking ….
![Page 6: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/6.jpg)
While you are thinking ….
If you are dealing with TB – THINK HIVTBC tests for HIV in those wesee with a positive TST age 14and up
If you are dealing with HIV – THINK TB
![Page 7: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/7.jpg)
Look for Early TB
![Page 8: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/8.jpg)
Look for Early TB
• Cough 4/52 or more (If a smoker look for persistent change in cough of 4/52)
• Unexplained fever of > 1/52• Antibiotic resistant pneumonia (on CXR)
May not be TB but check for it:sputumCXR
![Page 9: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/9.jpg)
Get Specimens
![Page 10: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/10.jpg)
Get Specimens
Specimens help to:– Confirm/exclude diagnosis• Without a + culture the diagnosis remains presumptive
– Identify the organism– Identify drug sensitivities
![Page 11: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/11.jpg)
Get Specimens
• “If they are coughing get sputum” – do it now while they are in clinic– but also try to get some morning sputa
• 3 AM sputa maximizes yield• Consider inducing the sputum if necessary• With Miliary TB may also consider urine, bone
marrow• With very low CD4 count consider blood culture
for TB
![Page 12: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/12.jpg)
Understand the Limitations of Radiology
![Page 13: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/13.jpg)
Understand the Limitations of Radiology
• CXR & CT are crucial parts of TB evaluation BUT
![Page 14: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/14.jpg)
Understand the Limitations of Radiology
• CXR & CT finding may suggest TB but do not prove it– e.g. recent case
• Normal CXR does not exclude active TB– (Marciniuk Chest 1999;115:445-452)
• TB has typical patterns but can look like anything on CXR
![Page 15: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/15.jpg)
Look at the Whole Picture
![Page 16: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/16.jpg)
Look at the Whole Picture
As with any illness, look at the whole picture don’t just treat a test.
historyphysicaltests, CXR’senvironment
![Page 17: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/17.jpg)
Focus of Contact Tracing
![Page 18: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/18.jpg)
Focus of Contact Tracing
Primary TB – looking for someone who is coughing (looking for source)
- age 15 & up
Active smear + (culture +) TB – looking for spread
- age <5- HIV+, other immunosupression
![Page 19: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/19.jpg)
Never Monotherapy
![Page 20: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/20.jpg)
Never Monotherapy
Why?
![Page 21: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/21.jpg)
Never Monotherapy
Monotherapy will inevitably lead to drug resistance
![Page 22: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/22.jpg)
Why two drugs?
• The organisms in a large active population e.g. cavity, will innately have some organism resistant to a drug.
• The chance of an organism being resistant to two drugs is so small as to be non-existent .
• When starting active treatment, want two drugs that the person has not been previously exposed to
![Page 23: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/23.jpg)
How treatment failure can occur
![Page 24: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/24.jpg)
Treatment Failure• Non-compliance
• No drugs work if you don’t take them
• Large rapidly growing population - selection of resistant organisms
• Must have at least two drugs the organisms are sensitive to• Prescription error• Patient decides to delete one drug
• Slow growing population - persistent organisms• Drugs not continued long enough• Long enough but not enough doses in the alotted time
![Page 25: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/25.jpg)
Where TB organisms live
![Page 26: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/26.jpg)
Location Vs Drug Effectiveness
Activity on organismsCavity
Macroph CaseumSM +++ 0
0INH ++ +
0RMP ++ +
+EMB +/- +/-
0PZA 0 +
+ 0
![Page 27: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/27.jpg)
Activity of First-Line Drugs
![Page 28: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/28.jpg)
Why DOT?
![Page 29: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/29.jpg)
Why DOT?
Cochrane Review trashed it!
![Page 30: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/30.jpg)
407 cases of SAT, then switched to 581 of DOT, results are despite higher IV drug use, more homelessness and rising TB rates
Weis et al NEJM 1994;330:1179-1184
DOT•Identifies compliance issues quickly (audit)•Ensures drugs are taken together
![Page 31: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/31.jpg)
Active Disease Risks
![Page 32: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/32.jpg)
Active Disease Risk
1st yr, 2nd yr, 3-4, 5-10, 10+
10%
50%Pulm 30-40M/M 10-20
20-30%
Untreated TB Infection
Pulm 1-20M/M 2-5
![Page 33: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/33.jpg)
Infection Risks
Can StdsP 184
![Page 34: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/34.jpg)
Active Disease Risks
20-30%2-5x 20-30x 100+x
Granuloma on CXR (2) fibronodular on CXR (6-19) HIV infection (50-110)Smoke 1 ppd (2-3) TB infection within 2 yrs (!%) AIDS (110-170)infected age 0-4 (2.2-5) CA head & neck (16)<90% ideal wt (2-3) CRF on hemodialysis (10-25)DM (2-3.6) silicosis (30)TNF inhibitors (1.5-4) Transplantation (20-74)CS Rx (4.9)
Untreated TB infectionCompared with infected person with
No risk factors & normal CXR
![Page 35: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/35.jpg)
Active TB Risk Factors
![Page 36: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/36.jpg)
Infection Risks
Can StdsP 65
![Page 37: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/37.jpg)
TST Screening & BCG status
Saskatchewan study comparing young kids who had or did not have neonatal BCG vaccination:
At age 4 – no difference – TST 10 mm valid
< age 4 - TST 15 mm validTST < 15 “grey area”
consider community & age risk
Reid et al: Chest 2007;131;1806-1810
![Page 38: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/38.jpg)
Can doctors or nurses predict which patient will be compliant
with medications use?
![Page 39: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/39.jpg)
NO!
![Page 40: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/40.jpg)
What is this?
![Page 41: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/41.jpg)
6 months earlier
![Page 42: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/42.jpg)
* usually resolves spontaneously* active TB will develop in up to 60%* usually unilateral*more common in young men* DTH reaction to a few bacilli* smear negative fluid, culture positive in only 1/3*pleural biopsy for diagnosis* Induced sputum may be positive
Tuberculous Pleural Effusion
![Page 43: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/43.jpg)
How does HIV change TB Management
![Page 44: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/44.jpg)
How does HIV change TB Management
• Test for HIV– All active TB cases– Contacts if at risk for HIV – Contacts if index cases is HIV-TB co-infection
• TST– 5 mm is positive IN HIV+ PATIENT– Sensitivity decreases as CD4 count decreases
![Page 45: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/45.jpg)
How does HIV change TB Management
• Active TB in HIV+– May lack typical clinical & CXR features• More LN, pleural, meningeal, pericardial involvement• CXR may be normal
– Aggressive sampling• Sputums even if CXR normal• Blood culture if CD4 <50-100
– If negative TST, consider repeat after ART & immune reconstitution
![Page 46: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/46.jpg)
How does HIV change TB Management
• LTBI in HIV+– Treat unless well documented previous treatment– ? Benefit of Rx in TST- or anergic HIV+– HIV+ with recent infectious TB exposure – treat for
LTBI regardless of TST status• High re-infection risk in HIV+
– Consider LTBI Rx for HIV+ TST-:• High epidemiologic risk• CXR features suggest past TB
– Treat LTBI in pregnancy
![Page 47: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/47.jpg)
How does HIV change TB Management
• Tx of TB in HIV+– The good news – for fully sensitive TB the
following are the same as in HIV- cases:• Cure rates• Clinical response rate• Culture conversion time• Relapse rates
![Page 48: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/48.jpg)
How does HIV change TB Management
• Tx of TB in HIV+– RMP (rifamycins) very important– BUT .. RMP interferes with some AR drugs
• TB & HIV docs need to connect
– Rx for 9/12 may be wiser than shorter courses– If CD4 <100 do not use RMP less than 3x/wk
• Increased RMP resistance
– ? Reduced absorption of RMP & EMB in HIV+– DOT is standard– HIV+ may be more prone to INH neuropathy
• B6 25 mg
– Initiate ART early
![Page 49: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/49.jpg)
If you want things to happen(want service)
![Page 50: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/50.jpg)
If you want things to happen(want service)
Phone
Don’t just send a letteror requisition
e.g. x-ray req’n
![Page 51: W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S TB 101 for Primary Care Providers](https://reader036.vdocuments.net/reader036/viewer/2022062620/551ac97d550346b2288b5839/html5/thumbnails/51.jpg)
TheEnd